Predictors of Placebo Response in Pooled Lamotrigine Neuropathic Pain Clinical Trials

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The Clinical Journal of Pain

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/AJP.0b013e31819dddedPMID 19542793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Placebo response in neuropathic pain trials☆

  2008cited by this paper
• Clinical trial outcome in neuropathic pain

  2008cited by this paper
• Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.

  2007cited by this paper
• Lamotrigine for treatment of pain associated with diabetic neuropathy: Results of two randomized, double‐blind, placebo‐controlled studies

  2007influential reference
• The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain

  2007cited by this paper
• A randomized, placebo‐controlled study of oxcarbazepine in painful diabetic neuropathy

  2006cited by this paper
• A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain

  2006cited by this paper
• Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13‐week, randomized trial

  2006cited by this paper
• Oxcarbazepine in painful diabetic neuropathy: results of a dose‐ranging study

  2006cited by this paper
• Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo‐controlled study

  2005cited by this paper
• Duloxetine vs. placebo in patients with painful diabetic neuropathy

  2005cited by this paper
• Reversible cervical hydromyelia in subacute combined degeneration

  2005cited by this paper
• A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

  2005cited by this paper
• Mechanisms of the placebo response and their impact on clinical trials and clinical practice

  2005cited by this paper
• Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain

  2005cited by this paper
• Efficacy of pregabalin in neuropathic pain evaluated in a 12‐week, randomised, double‐blind, multicentre, placebo‐controlled trial of flexible‐ and fixed‐dose regimens

  2005cited by this paper
• Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double‐blind, placebo‐controlled trial

  2004cited by this paper
• Topiramate in painful diabetic polyneuropathy: findings from three double‐blind placebo‐controlled trials

  2004cited by this paper
• Pregabalin reduces pain and improves sleep and mood disturbances in patients with post‐herpetic neuralgia: results of a randomised, placebo‐controlled clinical trial

  2004cited by this paper
• Pregabalin for the treatment of postherpetic neuralgia

  2003cited by this paper
• Gabapentin in neuropathic pain syndromes: a randomised, double‐blind, placebo‐controlled trial

  2002cited by this paper
• Clinical importance of changes in chronic pain intensity measured on an 11‐point numerical pain rating scale

  2001cited by this paper
• Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial

  1999cited by this paper
• Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.

  1998cited by this paper
• Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

  1998cited by this paper
• The importance of placebo effects in pain treatment and research.

  1994cited by this paper

• The Impact of Screening Period Pain Inconsistency on Placebo Response in Intra-Articular Knee Osteoarthritis Trials.

  2025cites this paper
• Minimizing placebo responses in clinical trials.

  2025cites this paper
• The prediction of the analgesic placebo effect is moderated by direction of attention: results from fibromyalgia and healthy controls.

  2025cites this paper
• Psychometric properties of the Hebrew KIDSCREEN 52, 27 and 10 items: a cross-sectional study of self and parents reports in youth with and without physical disabilities

  2025cites this paper
• Placebo effects in neuropathic pain conditions.

  2024cites this paper
• Mediators of Placebo Response to Cannabinoid Treatment in Children with Autism Spectrum Disorder

  2023cites this paper
• Conditioned open-label placebo for opioid reduction after spine surgery: a randomized controlled trial

  2022cites this paper
• Impact of variability in baseline pain on the placebo response in randomized, placebo-controlled, crossover trials in peripheral neuropathic pain.

  2021cites this paper
• Greater baseline pain inclusion criteria in clinical trials increases regression to the mean effect: a modelling study.

  2021cites this paper
• Efficacy of an occluding toothpaste on dentinal hypersensitivity over 14 days

  2021cites this paper
• Conditioned open-label placebo for opioid reduction following spine surgery: a randomized, controlled trial.

  2021cites this paper
• Meta-analysis comparing placebo responses in clinical trials of painful HIV-associated sensory neuropathy and diabetic polyneuropathy

  2020cites this paper
• Factors with impact on magnitude of the placebo response in randomized, controlled, cross-over trials in peripheral neuropathic pain.

  2020cites this paper
• Historical Controls in Randomized Clinical Trials: Opportunities and Challenges

  2020cites this paper
• Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs

  2020cites this paper
• Is There Clinical Improvement Associated With Intradiscal Therapies? A Comparison Across Randomized Controlled Studies

  2020cites this paper
• The use of ketamine in the management of refractory cancer pain in a palliative care unit.

  2020cites this paper
• Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice

  2020cites this paper
• NEUROPATHIC PAIN SECTION Original Research Article Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis

  2016cites this paper
• Clinically Effective Treatment of Fibromyalgia Pain With High-Definition Transcranial Direct Current Stimulation: Phase II Open-Label Dose Optimization.

  2016cites this paper
• Mechanisms of the placebo effect in pain and psychiatric disorders

  2016cites this paper
• Meta-analysis of placebo responses in central neuropathic pain: impact of subject, study, and pain characteristics

  2016cites this paper
• Predictors of Response in Patients With Postherpetic Neuralgia and HIV-Associated Neuropathy Treated With the 8% Capsaicin Patch (Qutenza)

  2015cites this paper
• Predictors of the placebo analgesia response in randomized controlled trials of chronic pain: a meta-analysis of the individual data from nine industrially sponsored trials

  2015cites this paper
• An Investigation of Factors Contributing to Higher Levels of Placebo Response in Clinical Trials in Neuropathic Pain: A Systematic Review and Meta-Analysis

  2015cites this paper
• Epidermal growth factor receptor-inhibition (EGFR-I) in the treatment of neuropathic pain.

  2015cites this paper
• Understanding the placebo response in neuropathic pain drug treatment trials

  2014cites this paper
• FoxO Transcription Factors Support Oxidative Stress Resistance in Human Chondrocytes

  2014cites this paper
• Meta‐Analysis of Assay Sensitivity and Study Features in Clinical Trials of Pharmacologic Treatments for Osteoarthritis Pain

  2014cites this paper
• Assay sensitivity and study features in neuropathic pain trials

  2013cites this paper
• Listening to placebo in clinical trials for female sexual dysfunction.

  2013cites this paper
• Placebo and nocebo effects in randomized controlled trials: the implications for research and practice.

  2013cites this paper
• Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis.

  2012cites this paper
• Predictors of placebo response in adults with attention-deficit/hyperactivity disorder: data from 2 randomized trials of osmotic-release oral system methylphenidate.

  2012cites this paper
• Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain.

  2012cites this paper
• Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations

  2012cites this paper
• Efficient assessment of efficacy in post-traumatic peripheral neuropathic pain patients: pregabalin in a randomized, placebo-controlled, crossover study

  2012cites this paper
• Systematic review: Placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy—magnitude and patient-related predictors

  2011cites this paper
• Nanocrystal Formulations for Improved Delivery of Poorly Soluble Drugs

  2011cites this paper
• The enigma of diagnosing and managing diabetic peripheral neuropathic pain in everyday practice: time to QOF up?

  2011cites this paper
• Night-to-night variability of sleep latency significantly predicts the magnitude of subsequent change in sleep latency during placebo administration.

  2011cites this paper
• Evidence‐based clinical trial design for chronic pain pharmacotherapy: A blueprint for ACTION

  2011cites this paper
• Placebo Effects in Neurological Diseases

  2010cites this paper
• diabetic neuropathy Review : Novel insights on diagnosis , cause and treatment of diabetic neuropathy : focus on painful

  2010cites this paper
• Review: Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy

  2010influential citation
• The Placebo Response

  2010cites this paper
• Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations

  2010cites this paper
• Advances in clinical research methodology for pain clinical trials

  2010cites this paper